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ABSTRACT
Background: In addition to providing greater comfort and 
convenience for the patient, the radial approach is associated 
to lower rates of vascular complications and major bleeding, 
with potential impact on morbidity and mortality. Thus, the 
adoption of strategies that reduce the risk of arterial occlusion 
after invasive procedures, enabling it to be reused, is desirable. 
Methods: Controlled prospective registry evaluating the impact 
of routine adoption of a selective radial compression device 
in patients with acute coronary syndrome without ST-segment 
elevation undergoing early invasive stratification through the 
radial access. Arterial patency was assessed by the Barbeau 
test at hospital discharge and at the 30-day follow-up. Results: 
Fifty-nine patients were evaluated, of which 83% underwent ad 
hoc percutaneous coronary intervention. Mean age was 64 ± 
12.2, 66.1% were male and 28.8% had diabetes mellitus. The 
right radial access was used in 98.3% of cases, the number of 
catheters was 2.4 ± 0.6, with a diameter of 6 F in all cases, 
and the duration of the procedure was 32.4 ± 12.7 minutes. 
Spasm was reported in 10.2% of cases, hematoma > 5 cm in 
3.4% and occlusion of the radial artery after the procedure 
and at 30 days in 6.8% and 3.4% of the cases, respectively. 
Conclusions: The TR Band® radial compression device is safe 
and effective in obtaining reduced rates of radial artery oc-
clusion after invasive coronary procedures.
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RESUMO
Utilização de Pulseira Compressora Seletiva  
na Prevenção da Oclusão da Artéria  
Radial Após Procedimento Coronário Invasivo
Introdução: O acesso radial, além de propiciar maior conforto 
e comodidade, associa-se a menores taxas de complicações 
vasculares e sangramento grave, com potencial impacto na 
morbimortalidade. Assim, é desejável a adoção de estratégias 
que reduzam o risco de oclusão arterial após procedimentos 
invasivos, possibilitando sua reutilização. Métodos: Registro 
prospectivo, controlado, que avaliou o impacto da utilização 
rotineira de pulseira compressora seletiva em pacientes com 
síndrome coronariana aguda sem supradesnivelamento do 
ST submetidos à estratificação invasiva pelo acesso radial. A 
patência arterial foi avaliada por meio do teste de Barbeau, na 
alta hospitalar e aos 30 dias de evolução. Resultados: Foram 
avaliados 59 pacientes, dos quais 83% realizaram intervenção 
coronária percutânea ad hoc. A média de idades foi de 64 ± 
12,2 anos, 66,1% eram do sexo masculino e 28,8% portado-
res de diabetes mellitus. O acesso radial direito foi utilizado 
em 98,3% das intervenções, o número de cateteres foi 2,4 
± 0,6, com diâmetro de 6 F em todos os casos, e a duração 
dos procedimentos foi de 32,4 ± 12,7 minutos. Espasmo foi 
reportado em 10,2%, hematoma > 5 cm em 3,4% e oclusão 
da artéria radial após o procedimento e aos 30 dias em 6,8 
e 3,4% dos casos, respectivamente. Conclusões: A pulseira 
compressora TR Band® é dispositivo seguro e eficaz na obten-
ção de taxas reduzidas de oclusão radial, após procedimento 
coronário invasivo.
DESCRITORES: Artéria radial. Intervenção coronária percutâ-
nea. Hemostasia.
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W hen compared to femoral access, the radial access is associated with a lower rate of complications at the arterial puncture site, allows for earlier 
ambulation, provides greater comfort to the patient after 
the procedure, and shows proven cost-effectiveness.1,2 
Current trials indicate that the choice of the radial 
technique brings benefit in reducing mortality during 
percutaneous coronary intervention (PCI) and primary 
combined rate of death, myocardial infarction (AMI), 
and stroke in patients with acute coronary syndrome 
(ACS) undergoing invasive stratification in centers clas-
sified as having high-volume for this access route.3,4 
Thus, the adoption of strategies that reduce the risk 
of radial artery occlusion after coronary procedure is 
desirable, allowing its reutilization.
In spite of device miniaturization increasing the 
ratio between the arterial diameter and the sheath, 
use of hydrophilic materials, systematic hepariniza-
tion, and spasmolytic drug infusions, the rate of radial 
artery occlusion evaluated by plethysmography remains 
between 7 and 12%.5 The aim of this study was to 
determine the incidence of radial artery occlusion 
after routine use of a selective radial compression 
device, aiming to attain hemostasis while maintain-
ing antegrade flow in patients with ACS managed 
through invasive procedure. 
METHODS
Prospective registry, controlled, that assessed the 
efficacy and safety of the TR Band® (Terumo Medical, 
Tokyo, Japan) selective compression device in prevent-
ing vascular complications at the radial puncture site, 
with emphasis on the rate of arterial occlusion, after 
invasive coronary procedures. 
The outcomes of interest, i.e., occlusion of the 
radial artery, hematoma, pseudoaneurysm, arteriovenous 
fistula, compartment syndrome, and severe bleeding, 
were evaluated during hospitalization and on the 30th 
day of follow-up, during medical consultation. 
The pre-procedural permeability of the palmar arch 
was assessed through Allen’s test and the oximeter test.6 
The plethysmographic patterns were classified as type A 
(no wave attenuation after radial artery compression), 
B (wave attenuation), C (transitory loss of tracing, rees-
tablished within 2 min) and D (loss of tracing without 
wave restoration).
Definitions
Asymptomatic arterial occlusion was defined as the 
interruption of arterial blood flow, without manifestations 
of cell metabolism impairment or blood tissue failure. 
Severe bleeding was defined as type 3 (3a – bleeding 
with hemoglobin decrease ≥  3  g/dL and <  5  g/dL or 
packed red blood cell transfusion; 3b – bleeding with 
hemoglobin decrease ≥ 5 g/dL, or cardiac tamponade, 
or bleeding requiring surgical intervention, or bleeding 
requiring intravenous vasoactive drug use; or 3c – in-
tracranial hemorrhage, or subcategories confirmed by 
autopsy, imaging assessment, or lumbar puncture, or 
intraocular bleeding with vision impairment) or type 5 
(5a – likely fatal bleeding, and 5b-definitive fatal bleed-
ing).6 The hematomas were graded as type I, ≤  5  cm 
in diameter; type II, ≤  10  cm; or type III, >  10  cm, 
without reaching the elbow; type IV, hematoma extend-
ing beyond the elbow; or type V, any hematoma with 
ischemic injury to the hand.7 Clinical success was 
defined as PCI performance with reduction of target 
stenosis to a diameter <  20%, while maintaining or 
restoring normal antegrade flow (Thrombolysis in 
Myocardial Infarction (TIMI) grade 3), and absence 
of severe clinical complications (death, AMI, or 
coronary artery bypass graft surgery [CABG]). Device 
success was defined as achievement of adequate 
hemostasis at the end of the procedure using the TR 
Band® selective compression device, with no need to 
change to a compressive dressing. The duration of 
the procedure and fluoroscopy time were measured 
from the beginning of arterial puncture until sheath 
withdrawal.
Hemostasis technique while maintaining 
antegrade flow
To achieve hemostasis, the TR Band® radial com-
pression device was used according to the previously 
validated protocol.8 Immediately after the procedure, 
the sheath was withdrawn by approximately 2 cm. The 
device was applied to the patient with a green marker 
(located in the center of the largest balloon) positioned 
exactly at the puncture orifice, facilitating the localiza-
tion, visualization, and control of possible bleeding. 
The balloon was inflated with the appropriate syringe 
and 15 mL of air was injected, with simultaneous and 
complete withdrawal of the sheath, observing, at the 
end, the absence of active bleeding. After the fourth 
hour and at each subsequent hour (fifth and sixth hours), 
5 mL of air were slowly released, keeping the balloon 
connected to the syringe and controlling the plunger 
with the thumb. In case of bleeding at any stage of 
device withdrawal, the required volume of air was 
once again injected to maintain hemostasis, repeating 
the process after 60 minutes.
The maintenance of antegrade flow was measured 
by the plethysmographic curve obtained at the ipsilateral 
thumb to the puncture. Once the compression device 
was applied, the ulnar wrist was compressed, and the 
oximetric curve was verified in a period of up to two 
minutes, indicating patent flow. If the curve was not 
restored, the bracelet balloon gradually emptied until it 
was restored, and the occurrence of bleeding was the 
limiting factor. In the event of device failure, hemostasis 
was obtained with compressive dressing, using a porous 
adhesive elastic bandage.
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Assessment of radial artery patency
Radial artery patency was assessed 24 hours after 
the procedure and on the 30 day follow-up using Bar-
beau’s test.9 By placing a pulse oximeter on the patient’s 
thumb, the appearance of the plethysmographic wave 
was verified. Subsequently, radial and ulnar arteries 
were compressed until the disappearance of the signal. 
Releasing only the radial artery, wave restoration was 
verified, confirming its patency, and its lack of restora-
tion was interpreted as arterial occlusion.
Statistical analysis
Qualitative variables were summarized as absolute 
frequencies and percentages. Quantitative data were 
described as means and standard deviations.
RESULTS
From July 2013 to February 2014, 59 patients 
diagnosed with ACS without ST elevation were submit-
ted to early invasive stratification. The mean age was 
64  ±  12.2 years, 66.1% were male, and 28.8% had 
diabetes mellitus. 
Regarding the indications, risk scores, and character-
istics of the procedures, the high percentage of patients 
with AMI without ST elevation (86.4%), GRACE score 
≥ 140 in 47.5% of cases and ad hoc PCI in 83.1% of 
cases are noteworthy. (Tables  1 and 2).
Angiographic and clinical success was achieved in 
96.0% and 93.9% of the PCIs, respectively (Table 3). 
Radial hemostasis with antegrade flow maintenance 
was achieved in 84.7% of patients. In the remaining 
patients, despite the use of the selective compression 
device, an oximetric curve consistent with arterial pa-
tency was not identified. The rate of hematoma at the 
puncture site was 3.4% (all type II), and the arterial 
occlusion incidence after the procedure and at 30 days 
was 6.8% and 3.4%, respectively, with no evidence of 
ischemic injury to the hand (Table 4).
DISCUSSION
Radial artery occlusion is the most reported com-
plication with this access route, whose incidence has 
ranged from 1.5 to 33%.10,11 Although asymptomatic in 
most cases, with rare reports of severe ischemia, this 
occurrence prevents its use in future procedures. Once 
diagnosed, up to 50% of cases may show spontaneous 
recanalization at 30 days; validated strategies for its 
prevention include 3,000-5,000  U of unfractionated 
heparin during the procedure, the use of hydrophilic 
sheaths and devices with lower diameter, and, more 
recently, the use of hemostasis techniques with antegrade 
flow maintenance.5,12,13
Its physiopathology is associated with an interaction 
of factors, such as local trauma, spasm, and occlusive 
thrombus formation. Predictors for its occurrence comprise 
female gender, young individuals, patients with diabetes 
mellitus, non-heparinization during the procedure, and 
absence of antegrade flow when attaining hemostasis.14 
In fact, compared to the conventional technique of 
hemostasis with compression bandage in 436 patients 
undergoing transradial coronary angiography, hemostasis 
with antegrade flow maintenance significantly reduced 
the rate of occlusion of the radial artery by 59 and 
75% 24 hours after and 30 days after the procedure, 
respectively.5
Evidence shows that the maintenance of radial 
artery patency during hemostasis is the most important 
TABLE 1  
Baseline clinical characteristics
n = 59
Age, years 64.1 ± 12.2
Male gender, n (%) 39 (66.1)
Body mass index, kg/m2 28.2 ± 5.01
Diabetes mellitus, n (%) 17 (28.8)
Systemic arterial hypertension, n (%) 46 (80.0)
Dyslipidemia, n (%) 25 (42.4)
Current smoking, n (%) 22 (37.3)
Family history of coronary artery 
disease, n (%)
15 (25.4)
Previous myocardial infarction, n (%) 5 (8.5)
Previous percutaneous coronary 
intervention, n (%)
3 (5.1)
Previous stroke, n (%) 2 (3.4)
Peripheral arterial disease, n (%) 3 (5.1)
Creatinine, mg/dL 1.0 ± 0.4
Chronic renal failure, n (%) 4 (6.8)
Clinical picture, n (%)
Unstable angina, n (%) 8 (13.6)
AMI without ST-elevation 51 (86.4)
ST-segment depression n (%) 18 (30.6)
Positive troponin I, n (%) 46 (80.0)
TIMI score, n (%)
0-2 6 (10.2)
3-4 38 (64.4)
5-7 15 (25.4)
GRACE score, n (%)
< 140 31 (52.5)
≥ 140 28 (47.5)
CRUSADE score, n (%)
≤ 30 37 (62.7)
31-40 12 (20.4)
≥ 41 10 (16.9)
TIMI; Thrombolysis in Myocardial Infarction.
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parameter for reducing the risk of arterial occlusion. In 
a randomized trial involving 400 coronary diagnostic 
procedures, the incidence of early (7%) and late (5%) 
radial occlusion in patients with antegrade flow dur-
ing the process of hemostasis were independent from 
the use of unfractionated heparin at the start of the 
examination.14 Thus, in selected cases, heparinization 
could be omitted in diagnostic procedures through 
radial access, as long as hemostasis was attained with 
maintenance of arterial patency.
In the present study, involving a population of 
patients with ACS of predominantly medium to high 
risk, despite the routine use of 6F sheaths, ad hoc per-
cutaneous coronary intervention in 83% of cases, the 
greater manipulation and the changing of catheters, and 
the mean duration of the procedure of 32 minutes, the 
authors obtained rates of arterial occlusion at discharge 
and at 30 days of 6.8% and 3.4%, respectively. The 
findings of the pre-procedure evaluation of palmar arch 
permeability through Allen’s test or oximetry do not 
TABLE 2  
Characteristics of procedures
n = 59
Normal Allen test, n (%) 54 (91.5)
Plethysmography, n (%)
A 12 (20.3)
B 40 (67.8)
C 3 (5.1)
D 4 (6.8)
Procedures, n (%)
Coronary angiography 10 (16.9)
Percutaneous coronary intervention 
ad hoc
49 (83.1)
Right radial access, n (%) 58 (98.3)
Access crossover, n (%) 0
6F sheath, n (%) 59 (100)
Number of catheters 2.4 ± 0.6
Contrast volume, mL 161.4 ± 49.8
Duration of procedure, minute 32.4 ± 12.7
Time of fluoroscopy, minute 9.3 ± 5.7
Sedation, n (%) 53 (89.8)
Periprocedural medications, n (%)
Unfractionated heparin 59 (100)
Acetylsalicylic acid 59 (100)
Clopidogrel 46 (80.0)
Ticagrelor 13 (20.0)
Coronary disease, n (%)
No obstructive lesions 10 (16.9)
Single-artery 28 (47.5)
Multiarterial 21 (35.6)
Ejection fraction, % 61.9 ± 17.4
TABLE 3  
Characteristics of the percutaneous coronary 
intervention
n = 49
Culprit artery, n (%)
Left anterior descending artery 28 (57.2)
Circumflex artery 8 (16.3)
Right coronary artery 13 (26.5)
Stent implant, n (%) 48 (98.0)
Number of stents 1.4 ± 0.5
Bare-metal stent, n (%) 47 (97.9)
Pre-dilation, n (%) 31 (63.3)
Post-dilation, n (%) 41 (83.7)
TIMI-pre, n (%)
0 13 (26.5)
1 3 (6.1)
2 9 (18.4)
3 24 (49.0)
TIMI-post, n (%)
0 1 (2.0)
1 0
2 471 (96.0)
3 47 (96.0)
Angiographic success, n (%) 47 (96.0)
Clinical success, n (%) 46 (93.9)
TIMI; Thrombolysis in Myocardial Infarction.
TABLE 4  
Device success and vascular complications at the 
arterial puncture site 
n = 59
Device success, n (%) 59 (100)
Procedure-discharge time, days 1.4 ± 0.9
Arterial spasm, n (%) 6 (10.2)
Type of hematoma, n (%)
I 0
II 2 (3.4)
III 0
IV 0
V 0
Severe bleeding, n (%) 0
Post-procedural radial artery occlusion, 
n (%)
4 (6.8)
Radial artery occlusion at 30 days, n (%) 2 (3.4)
represent contraindication to the procedure by radial 
approach, and cases with persistent arterial occlusion 
at 30 days did not exhibit an altered Allen’s test or 
plethysmographic curve type D in the initial screening.
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The main limitation of this analysis, in addition to 
the small sample size, was the non-routine performance 
of radial artery Doppler ultrasound prior to hospital 
discharge, which could underestimate the true incidence 
of complications,11 although the close correlation be-
tween Barbeau’s test, applied to all patients, and the 
findings of Doppler ultrasound has been described. In 
addition, this was a single-center, non-randomized study, 
performed in a service with high volume of procedures 
using the transradial approach.
CONCLUSIONS
The TR Band® selective compression device is safe 
and effective for attaining reduced rates of radial occlusion 
after performing invasive coronary procedures, adding 
to the validated strategies to prevent this complication.
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